The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.
Horizon: Validation of an improved method for rapid characterization of protein aggregates in biologic drugs for increased quality and safetySBC: OPTOFLUIDICS, INC. Topic: NA
Optofluidics and the University of Delaware propose to complete the development of the Horizon technology and carry out validation via a comprehensive multi-site study. The technology is a subvisible particle analyzer pioneered during Phase I. The technology is designed to fill two critical gaps in biopharmaceutical product development: (1) Scientists can count and image particles with current too ...SBIR Phase II 2017 Department of CommerceNational Institute of Standards and Technology
SBC: Quantum Diamond Technologies Inc Topic: NA
Magnetic nanoparticles are widely-used tools over a range of industries, but have particularly powerful biomedical applications for clinical and research diagnostics, clinical therapy, and basic life science research. Many of these applications require consistent sources for magnetic nanoparticles with narrow distributions of magnetic properties, but no technology is now commercially available for ...SBIR Phase II 2017 Department of CommerceNational Institute of Standards and Technology
SBC: NOVA SCIENTIFIC INCORPORATED Topic: N/A
NOVA Scientific proposes a high-resolution neutron imaging detector having a specialized neutron-sensitive electron amplified detection stage integrated with a cross-strip electronic readout capable of centroid averaging. Phase 1 efforts demonstrated spatial resolutions of 15 Âµm with high detection efficiency and moderate counting rates. The Phase 2 proposed program will carry out further detec ...SBIR Phase II 2006 Department of CommerceNational Institute of Standards and Technology